Cardiff Oncology's Onvansertib shows promise in treating RAS-mutated cancers, especially mCRC. See why I rate CRDF stock as a ...

We torture-test a dozen of the most popular text-to-image AI tools with a series of prompts designed to highlight their strengths and weaknesses. Here's how they stack up. I've been writing about ...

This inflammation pathway affects most patients with difficult-to-treat asthma, increasing the risk of exacerbations and hospitalization. It is also found in up to 80% of people with CRSwNP ...

Kaivan Khavandi, SVP at GSK, stated, "Simultaneous regulatory submissions for two indications highlight our confidence in depemokimab to help reduce the burden of both asthma and CRSwNP for patients ...

Similarly, the ANCHOR trials showed that depemokimab effectively reduced nasal polyp size and obstruction in CRSwNP patients compared to placebo. Depemokimab, a monoclonal antibody targeting ...

"Simultaneous regulatory submissions for two indications highlight our confidence in depemokimab to help reduce the burden of both asthma and CRSwNP for patients and health systems." Depemokimab ...

Similarly, the ANCHOR trials showed that depemokimab effectively reduced nasal polyp size and obstruction in CRSwNP patients compared to placebo. Depemokimab, a monoclonal antibody targeting ...

If approved, depemokimab will be the first ultra-long-acting biologic with 6-month dosing Submissions based on data from positive SWIFT and ANCHOR trials SWIFT-1 and -2 showed depemokimab reduced ...

Earlier this month, a newer patient came in to see me for a check-up and discussion about her extremely high cholesterol level. In her late 50s with a family history of early-age heart attack ...

Malaysia Image caption, Jannatul Maoua of Bangladesh catches out Asabi Callender of West Indies during their ICC Women's U19 T20 World Cup 2025 Super Six match at Bayuemas Oval in Kuala Lumpur ...